No human trial has characterized the side-effect profile of the blend specifically
Injectable Therapeutic PeptidesAn Adjunct to Regenerative Medicine and Sports Performance
Bioinformatics 27 , 15711572 (2011)
BPC-157 has been extensively studied for its effects on tissue repair, inflammation, and pain relief, making it a compelling candidate for managing chronic conditions such as arthritis
In the case of Pernicious Anaemia and B12 deficiency diagnosis and treatment, other guidance exists
While the move does not mean the compounds would necessarily become FDA-approved drugs, it would allow them to be prescribed and compounded in a regulated medical setting rather than being pushed into an unregulated, potentially shadowy marketplace